Genpact (G)
(Delayed Data from NYSE)
$37.57 USD
+0.01 (0.03%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $37.56 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$37.57 USD
+0.01 (0.03%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $37.56 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Zacks News
Veritone (VERI) Announces Completion of PandoLogic Buyout
by Zacks Equity Research
The buyout is expected to help Veritone (VERI) accelerate its push into the human resources and talent acquisition market.
IQVIA (IQV) Announces Collaboration With NRx Pharmaceuticals
by Zacks Equity Research
IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.
6 Reasons to Add Robert Half (RHI) to Your Portfolio Now
by Shuvra Shankar Dey
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market. It currently has a double-digit margin and is a solid revenue performer.
Here's Why Investors Should Buy TransUnion (TRU) Stock Now
by Zacks Equity Research
Strong business model and favorable socio-economic trends are aiding TransUnion (TRU).
Genpact (G) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Reasons to Add Insperity Stock (NSP) to Your Portfolio Right Now
by Zacks Equity Research
Insperity's (NSP) business is currently benefiting from strength in the professional employer organization or the PEO industry.
6 Reasons to Add FTI Consulting (FCN) to Your Portfolio Now
by Zacks Equity Research
FTI Consulting's (FCN) international operations help expand its geographic footprint and contribute to top-line growth.
Zacks.com featured highlights include: Best Buy, Atlas Air Worldwide, Genpact, Arch Capital and Nutrien
by Zacks Equity Research
Zacks.com featured highlights include: Best Buy, Atlas Air Worldwide, Genpact, Arch Capital and Nutrien
5 Stocks With Solid Sales Growth Worth Betting on Right Now
by Swayta Shah
Sales growth is a vital indicator of any company's financial health. Let's check Best Buy (BBY), Atlas Air Worldwide (AAWW), Genpact (G), Arch Capital Group (ACGL) & Nutrien (NTR) as these are likely to witness strong top-line growth.
Here's Why You Should Hold on to Accenture (ACN) Stock Now
by Zacks Equity Research
Strategic acquisitions and a solid cash position boost Accenture (ACN). Yet, higher talent cost is a headwind.
Here's Why Investors Should Retain Verisk (VRSK) Stock For Now
by Zacks Equity Research
Verisk (VRSK) is continuing its investments in people, data sets, analytic solutions, technology and complementary businesses.
Genpact (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Solid Business Model Aids TransUnion (TRU), High Debt Hurts
by Zacks Equity Research
Strong business model and favorable socio-economic trends boost TransUnion (TRU) stock. However, high debt is a headwind.
Genpact (G) Beats on Q2 Earnings, Stock Up 2.2% on Strong View
by Zacks Equity Research
Genpact's (G) second-quarter 2021 earnings and revenues improve year over year.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Genpact (G) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 22.22% and 2.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Genpact (G) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Genpact (G) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Genpact (G) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
Genpact (G) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Accenture (ACN) to Gain From AFS' Novetta Buyout: Here's How
by Zacks Equity Research
The acquisition is expected to expand Accenture's (ACN) digital capabilities and add quality to its work in the national security sector.
Zacks Industry Outlook Highlights: Genpact, The Brinks Co and Conduent
by Zacks Equity Research
Zacks Industry Outlook Highlights: Genpact, The Brinks Co and Conduent
3 Stocks From the Promising Outsourcing Space to Watch Out For
by Sanjana Goswami
The coronavirus-driven dependency on technology and accelerated adoption of cloud infrastructure should help the Zacks Outsourcing industry thrive. G, BCO and CNDT are well positioned to witness most of the surge in demand.
ManpowerGroup (MAN) Rides on Strong Cash Position, Cost Control
by Zacks Equity Research
A strong cash position enables ManpowerGroup (MAN) to pursue strategic acquisitions, invest in growth initiatives and return cash through dividend payment and share repurchases.
Accenture (ACN) Completes Acquisition of Homburg & Partner
by Zacks Equity Research
The buyout is expected to strengthen Accenture's (ACN) strategy and process capabilities, positioning it better for client's value creation.
Genpact (G) Beats on Q1 Earnings, Stock Down 7.1% on Weak View
by Zacks Equity Research
Strength in Global Clients business & increase in operating income drives Genpact's (G) first-quarter 2021 results.
Genpact (G) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 20.41% and 2.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?